Omkar Pharmachem Ltd.BSE: OMKARPH

Board Meeting Outcome for Outcome Of The Board Meeting Held On 13.08.2026

· Issued by Omkar Pharmachem Ltd. via BSE India

Filed with BSE ·

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 13 August, 2026 has considered and approved the following business:1. Unaudited Financial Results of the Company alongwith Limited Review Report for the quarter ended on 30" June, 2026.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Omkar Pharmachem Ltd. on 6ix

Earlier from Omkar Pharmachem

Later from Omkar Pharmachem

All Omkar Pharmachem news releases